0000899243-22-034467.txt : 20221028
0000899243-22-034467.hdr.sgml : 20221028
20221028183901
ACCESSION NUMBER: 0000899243-22-034467
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221027
FILED AS OF DATE: 20221028
DATE AS OF CHANGE: 20221028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McManus Kevin
CENTRAL INDEX KEY: 0001919560
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40657
FILM NUMBER: 221343354
MAIL ADDRESS:
STREET 1: C/O OMEGA THERAPEUTICS, INC.
STREET 2: 20 ACORN PARK D
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Therapeutics, Inc.
CENTRAL INDEX KEY: 0001850838
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 949-4360
MAIL ADDRESS:
STREET 1: 20 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-27
0
0001850838
Omega Therapeutics, Inc.
OMGA
0001919560
McManus Kevin
C/O OMEGA THERAPEUTICS, INC.
20 ACORN PARK DRIVE
CAMBRIDGE
MA
02140
0
1
0
0
Chief Human Resources Officer
Option (Right to Buy)
5.27
2022-10-27
4
A
0
55000
0.00
A
2032-10-26
Common Stock
55000
55000
D
The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.
/s/ Barbara Chan as Attorney-in-Fact for Kevin McManus
2022-10-28